Stock Track | Alebund Pharmaceuticals Soars 84.16% in Intraday Trading on Strong Hong Kong IPO Debut
Stock Track
Jun 29
ALEBUND-B (09637) shares soared 84.16% in intraday trading on Monday following its highly anticipated debut on the Hong Kong Stock Exchange.
The biopharmaceutical company's stock opened at HK$42 per share, significantly above its initial public offering price of HK$22.60. Alebund Pharmaceuticals raised approximately HK$1.18 billion in net proceeds from the IPO, which was heavily oversubscribed with the Hong Kong public offering portion 963.56 times subscribed.
The strong investor demand and substantial premium at opening reflect market optimism toward the company's prospects as it begins trading on the Hong Kong bourse.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.